Logo image of BUI.PA

BARBARA BUI (BUI.PA) Stock Fundamental Analysis

EPA:BUI - Euronext Paris - Matif - FR0000062788 - Common Stock - Currency: EUR

3.86  +0.04 (+1.05%)

Fundamental Rating

3

Overall BUI gets a fundamental rating of 3 out of 10. We evaluated BUI against 45 industry peers in the Textiles, Apparel & Luxury Goods industry. The financial health of BUI is average, but there are quite some concerns on its profitability. BUI has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

BUI had positive earnings in the past year.
In the past year BUI had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: BUI reported negative net income in multiple years.
In multiple years BUI reported negative operating cash flow during the last 5 years.
BUI.PA Yearly Net Income VS EBIT VS OCF VS FCFBUI.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M -4M

1.2 Ratios

BUI has a Return On Assets (2.73%) which is comparable to the rest of the industry.
With a decent Return On Equity value of 19.87%, BUI is doing good in the industry, outperforming 75.56% of the companies in the same industry.
Industry RankSector Rank
ROA 2.73%
ROE 19.87%
ROIC N/A
ROA(3y)0.46%
ROA(5y)-6.8%
ROE(3y)1.78%
ROE(5y)-33.1%
ROIC(3y)N/A
ROIC(5y)N/A
BUI.PA Yearly ROA, ROE, ROICBUI.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

1.3 Margins

Looking at the Profit Margin, with a value of 1.99%, BUI is doing worse than 68.89% of the companies in the same industry.
BUI has a Gross Margin of 74.58%. This is amongst the best in the industry. BUI outperforms 84.44% of its industry peers.
BUI's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 1.99%
GM 74.58%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.25%
GM growth 5Y2.61%
BUI.PA Yearly Profit, Operating, Gross MarginsBUI.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

More info and screens

4

2. Health

2.1 Basic Checks

BUI does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for BUI remains at a similar level compared to 1 year ago.
BUI has less shares outstanding than it did 5 years ago.
BUI has a better debt/assets ratio than last year.
BUI.PA Yearly Shares OutstandingBUI.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200K 400K 600K
BUI.PA Yearly Total Debt VS Total AssetsBUI.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M

2.2 Solvency

BUI has an Altman-Z score of 1.18. This is a bad value and indicates that BUI is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of BUI (1.18) is worse than 77.78% of its industry peers.
The Debt to FCF ratio of BUI is 2.01, which is a good value as it means it would take BUI, 2.01 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 2.01, BUI belongs to the top of the industry, outperforming 82.22% of the companies in the same industry.
A Debt/Equity ratio of 2.09 is on the high side and indicates that BUI has dependencies on debt financing.
With a Debt to Equity ratio value of 2.09, BUI is not doing good in the industry: 88.89% of the companies in the same industry are doing better.
Even though the debt/equity ratio score it not favorable for BUI, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 2.09
Debt/FCF 2.01
Altman-Z 1.18
ROIC/WACCN/A
WACC7.2%
BUI.PA Yearly LT Debt VS Equity VS FCFBUI.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M 6M

2.3 Liquidity

A Current Ratio of 1.15 indicates that BUI should not have too much problems paying its short term obligations.
BUI's Current ratio of 1.15 is on the low side compared to the rest of the industry. BUI is outperformed by 73.33% of its industry peers.
BUI has a Quick Ratio of 1.15. This is a bad value and indicates that BUI is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.74, BUI perfoms like the industry average, outperforming 53.33% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.15
Quick Ratio 0.74
BUI.PA Yearly Current Assets VS Current LiabilitesBUI.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

More info and screens

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 126.39% over the past year.
The Revenue has been growing slightly by 3.11% in the past year.
BUI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.80% yearly.
EPS 1Y (TTM)126.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%283.6%
Revenue 1Y (TTM)3.11%
Revenue growth 3Y10.13%
Revenue growth 5Y1.8%
Sales Q2Q%0.83%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BUI.PA Yearly Revenue VS EstimatesBUI.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 10.72, the valuation of BUI can be described as reasonable.
88.89% of the companies in the same industry are more expensive than BUI, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 26.32, BUI is valued rather cheaply.
Industry RankSector Rank
PE 10.72
Fwd PE N/A
BUI.PA Price Earnings VS Forward Price EarningsBUI.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

BUI's Price/Free Cash Flow ratio is rather cheap when compared to the industry. BUI is cheaper than 93.33% of the companies in the same industry.
Industry RankSector Rank
P/FCF 1.97
EV/EBITDA N/A
BUI.PA Per share dataBUI.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

BUI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BARBARA BUI

EPA:BUI (6/12/2025, 7:00:00 PM)

3.86

+0.04 (+1.05%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners75.36%
Ins Owner ChangeN/A
Market Cap2.59M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 10.72
Fwd PE N/A
P/S 0.21
P/FCF 1.97
P/OCF 1.67
P/B 2.09
P/tB 2.4
EV/EBITDA N/A
EPS(TTM)0.36
EY9.33%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.96
FCFY50.85%
OCF(TTM)2.31
OCFY59.86%
SpS18.48
BVpS1.85
TBVpS1.61
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.73%
ROE 19.87%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 1.99%
GM 74.58%
FCFM 10.62%
ROA(3y)0.46%
ROA(5y)-6.8%
ROE(3y)1.78%
ROE(5y)-33.1%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.25%
GM growth 5Y2.61%
F-Score7
Asset Turnover1.37
Health
Industry RankSector Rank
Debt/Equity 2.09
Debt/FCF 2.01
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 1.88%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 534.55%
Current Ratio 1.15
Quick Ratio 0.74
Altman-Z 1.18
F-Score7
WACC7.2%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)1.69%
Cap/Sales(5y)9.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)126.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%283.6%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)3.11%
Revenue growth 3Y10.13%
Revenue growth 5Y1.8%
Sales Q2Q%0.83%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y80.36%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y3752.78%
FCF growth 3Y1.7%
FCF growth 5YN/A
OCF growth 1Y456.84%
OCF growth 3Y-10.52%
OCF growth 5YN/A